Gain Therapeutics Inc.
(GANX)
undefined
undefined%
At close: undefined
1.50
-7.98%
Pre-market Dec 16, 2024, 04:03 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -22.27M | -17.59M | -13.89M | -3.58M | -2.19M | -1.11M |
| Depreciation & Amortization | 83.58K | 64.17K | 15.48K | 9.59K | 2.57K | 741.00 |
| Stock-Based Compensation | 3.26M | 1.53M | 839.37K | 81.64K | - | - |
| Other Working Capital | 1.09M | 448.15K | 34.70K | -129.31K | 218.99K | 201.55K |
| Other Non-Cash Items | -383.19K | -206.86K | -34.13K | 8.71K | 10.10K | 41.05K |
| Deferred Income Tax | - | - | 1.09M | - | - | - |
| Change in Working Capital | 442.23K | 1.51M | -385.11K | 237.50K | 312.26K | 319.23K |
| Operating Cash Flow | -18.87M | -14.69M | -12.37M | -3.24M | -1.87M | -744.51K |
| Capital Expenditures | -15.36K | -118.95K | -94.21K | -20.83K | -13.72K | -7.99K |
| Acquisitions | - | 14.66M | - | - | - | - |
| Purchase of Investments | -1.96M | -17.74M | - | - | - | - |
| Sales Maturities Of Investments | 12.19M | 3.08M | - | - | - | - |
| Other Investing Acitivies | - | -14.66M | - | - | - | 7.99K |
| Investing Cash Flow | 10.22M | -14.77M | -94.21K | -20.83K | -13.72K | -7.99K |
| Debt Repayment | -89.07K | -78.77K | -21.95K | 738.28K | - | 983.78K |
| Common Stock Repurchased | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - |
| Other Financial Acitivies | 12.73M | - | -841.27K | 9.75M | 1.75M | - |
| Financial Cash Flow | 12.64M | -78.77K | 41.77M | 10.49M | 1.75M | 983.78K |
| Net Cash Flow | 4.49M | -29.57M | 29.41M | 7.19M | -97.19K | 237.88K |
| Free Cash Flow | -18.88M | -14.81M | -12.46M | -3.26M | -1.88M | -752.50K |